Invention Grant
- Patent Title: CD8A-binding fibronectin type III domains
-
Application No.: US17689869Application Date: 2022-03-08
-
Publication No.: US11932680B2Publication Date: 2024-03-19
- Inventor: Rebecca Hawkins , Steven Jacobs , Manuel Sepulveda
- Applicant: JANSSEN BIOTECH, INC.
- Applicant Address: US PA Horsham
- Assignee: Janssen Biotech, Inc.
- Current Assignee: Janssen Biotech, Inc.
- Current Assignee Address: US PA Horsham
- Agency: Ice Miller LLP
- Main IPC: C07H21/04
- IPC: C07H21/04 ; A61K49/00 ; A61K51/08 ; C07K14/78 ; C12N5/02 ; C12N15/74 ; C12N15/87 ; C12P21/06 ; G01N33/53 ; G01N33/566 ; G01N33/569 ; G01N33/574 ; G01N33/68
Abstract:
Fibronectin type III domains (FN3) that specifically bind to CD8A, related polynucleotides capable of encoding CD8A-specific FN3 domains, cells expressing the FN3 domains, as well as associated vectors, and detectably labeled FN3 domains are useful in therapeutic and diagnostic applications.
Public/Granted literature
- US20230143550A1 CD8A-Binding Fibronectin Type III Domains Public/Granted day:2023-05-11
Information query
